服务热线
Anti-ERBB2/CD340/HER2;TNFRSF9/CD137/4-1BB mAbs [Nesfrotamig Biosimilar] (MABL-4982)
Anti-ANGPT2 mAbs [Nesvacumab Biosimilar] (MABL-4983)
Anti-IL17A mAbs [Netakimab Biosimilar] (MABL-4984)
Anti-FOLH1/GCPII/PSMA;CD28 mAbs [Nezastomig Biosimilar] (MABL-4985)
Anti-ERBB3/HER3 mAbs [Nezutatug Biosimilar] (MABL-4986)
Anti-SIGLEC2/CD22 mAbs [Moxetumomab Biosimilar] (MABL-4954)
Anti-SIGLEC2/CD22 mAbs [Mozistobart Biosimilar] (MABL-4955)
Anti-AMHR2 mAbs [Murlentamab Biosimilar] (MABL-4956)
Anti-NT5E/CALJA/CD73 mAbs [Mupadolimab Biosimilar] (MABL-4957)
Anti-CD3E mAbs [Muromonab Biosimilar] (MABL-4958)
Anti-CTLA4/CD152 mAbs [Muzastotug Biosimilar] (MABL-4959)
Anti-GFRA3 mAbs [Nadecnemab Biosimilar] (MABL-4960)
Anti-IL1RAP mAbs [Nadunolimab Biosimilar] (MABL-4961)
Anti-CSF2 mAbs [Namilumab Biosimilar] (MABL-4962)
Anti-TPBG/WAIF1 mAbs [Naptumomab Biosimilar] (MABL-4963)
联系我们
Copyright © 2012-2029 西安迈博睿（Mabioway）生物科技有限公司 版权所有
地址：陕西省西安市浐灞生态区广运潭大道南段4555号长安大学科技园4号楼A单元2层
电话：15339069646 邮箱：info@mabioway.cn
陕ICP备2021006339号
![Anti-ERBB2/CD340/HER2;TNFRSF9/CD137/4-1BB mAbs [Nesfrotamig Biosimilar] (MABL-4982)](/uploads/allimg/2025/11/02/743e6ba66fe5169f8bb51caae78c7dad.png)
![Anti-SIGLEC2/CD22 mAbs [Moxetumomab Biosimilar] (MABL-4954)](/uploads/allimg/2025/11/02/055e19ade1948fd8c3eaa6f867094efb.png)